Clinical Trial Update: Gefitinib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors or Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating gefitinib in combination with chemotherapy for patients with advanced solid tumors or colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Gefitinib (Gefitinib)

Snippet

Sponsor: Stanford University | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED